Newsroom
Category
April 20, 2018
se E. Cavazos, M.D., Ph.D., professor of neurology and physiology at UT Health San Antonio and assistant dean of the institution’s M.D./Ph.D. program, reviewed clinical studies of the drug, which would be sold under the brand name Epidiolex.
April 18, 2018
The symposium celebrates accomplishments in all areas of research, including education, public health, clinical sciences and basic sciences.
April 16, 2018
The campaign seeks to inform consumers that the work of UT Health San Antonio improves the entire spectrum of health care.
April 9, 2018
Komen Scholars are an advisory group of distinguished leaders in breast cancer research and advocacy. Dr. Ramirez will also receive $600,000 for Latino breast cancer research.
April 5, 2018
The groundbreaking technology could revolutionize studies of pancreatic cancer initiation and progression, and spur new drug development.
March 29, 2018
Team led by Patricia Dahia, M.D., Ph.D., of UT Health San Antonio.
